Zhang et al. prepared NPs with mesoporous silica as the shell, and found that these NPs displayed great biocompatibility in vivo and editing efficiency of EGFR of more than 60%, further achieving effective tumor gene therapy [88]. The gene discussed is EGFR; the disease is neoplasm.